Add BrightSurf on Google Email

Science News for October 17, 2004


Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Novel drug-antidote strategy provides greater control of drug action

Researchers at Duke University Medical Center have created a novel drug-antidote strategy that provides greater control of drug action. The breakthrough enables the development of matched drug-antidote pairs at the beginning of the drug development process, allowing for more precise treatment.

SourceDuke University Medical Center·JournalNature Biotechnology·DateOct 17, 2004

Hepatitis C virus linked to non-Hodgkin's lymphoma

Research in British Columbia found a seventeen-fold higher risk of diffuse large B-Cell lymphoma in HCV-infected patients. The study confirmed the viral-cancer link, previously suspected in studies from other regions with higher hepatitis C prevalence.

SourceAmerican Association for Cancer Research·DateOct 17, 2004

Diabetes hikes risk for liver, pancreatic cancers

Researchers found a three-fold increased risk of liver cancer among diabetic patients, which rose to almost four-fold when medication was used. Diabetes did not increase risks for other types of cancer, such as melanoma or colon cancer.

SourceAmerican Association for Cancer Research·DateOct 17, 2004
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.